Neoplasia/BPH

	Stereotactic reirradiation with Cyberknife(R) for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort. Radiol Med Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L. PMID: 37728816 [PubMed - as supplied by publisher]
	Early diagnosis and prognostic potential of RAC3 in bladder tumor. Int Urol Nephrol Wang S, Wei Z, Shu H, Xu Y, Fan Z, Shuang S, Li P, Lu P, Ye C. PMID: 37728806 [PubMed - as supplied by publisher]
	Recent insights on the clinical, pathological, and molecular features of intraductal carcinoma of the prostate. Int J Urol Naito Y, Kato M, Nagayama J, Sano Y, Matsuo K, Inoue S, Sano T, Ishida S, Matsukawa Y, Tsuzuki T, Akamatsu S. PMID: 37728330 [PubMed - as supplied by publisher]
	Comparison of Health-Related Quality of Life Changes in Prostate Cancer Patients Undergoing Laparoscopic versus Robotic-Assisted Laparoscopic Radical Prostatectomy: A Systematic review. Urol J Yazici S, Tonyali S. PMID: 37727913 [PubMed - as supplied by publisher]
	The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition. Front Immunol van Dorp J, van der Heijden MS. PMID: 37727793 [PubMed - in process]
	An exploratory study of unexplained concentration of (18)F-PSMA-1007 in the bladder for prostate cancer PET/CT imaging. Front Med (Lausanne) Dang J, Yao Y, Li Y, Tan X, Ye Z, Zhao Y, Qing S, Kou Y, Jiang X, Lu H, Chen S, Zhao M, Cheng Z. PMID: 37727766 [PubMed]
	Deep learning techniques for imaging diagnosis of renal cell carcinoma: current and emerging trends. Front Oncol Wang Z, Zhang X, Wang X, Li J, Zhang Y, Zhang T, Xu S, Jiao W, Niu H. PMID: 37727213 [PubMed]
	Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review. Front Oncol Yan L, Zhang Z, Wang T, Yuan L, Sun X, Su P. PMID: 37727211 [PubMed]
	A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients. BMC Med Huang H, Liu A, Liang Y, Xin Y, Liu J, Hao Y, Huang D, Chen L, Li W, Jiang G, Huang Y, Xu Y, Zhang J, Ma T, Xu D, Gao Y. PMID: 37726806 [PubMed - in process]
	Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study. Acta Oncol Storås AH, Tsuruda K, Fosså SD, Andreassen BK. PMID: 37725527 [PubMed - as supplied by publisher]
	An 18F-MD-PSMA (Multi-dentate PMSA Imaging Agent) PET/CT in Prostate Cancer Relapse: Results of a Retrospective Trial. Curr Radiopharm Fu H, Liang S, Xu M, Guo J, Liu Q, Kang J, Zhang L, Liu Z, Ding L, Ma Y, Yang B, Yao X, Qi J, Wang H, Cai Y. PMID: 37724670 [PubMed - as supplied by publisher]
	CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study. Cancer Imaging Song H, Yang S, Yu B, Li N, Huang Y, Sun R, Wang B, Nie P, Hou F, Huang C, Zhang M, Wang H. PMID: 37723572 [PubMed - indexed for MEDLINE]
	Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial). Sci Rep Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, Jarczyk J, Erben P, Bahlinger V, Goldschmidt F, Fechner G, Chen J, Paxinos E, Bates M, Haas M, Zengerling F, Bolenz C, Burger M, Hartmann A, Kriegmair MC, BRIDGE Consortium e.V.. PMID: 37723173 [PubMed - indexed for MEDLINE]
	Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis. Eur Urol Oncol Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Kói T, Ács N, Hegyi P, Hadaschik B, Nyirády P, Szarvas T. PMID: 37722977 [PubMed - as supplied by publisher]
	TGMIL: A hybrid multi-instance learning model based on the Transformer and the Graph Attention Network for whole-slide images classification of renal cell carcinoma. Comput Methods Programs Biomed Sun X, Li W, Fu B, Peng Y, He J, Wang L, Yang T, Meng X, Li J, Wang J, Huang P, Wang R. PMID: 37722310 [PubMed - as supplied by publisher]
	Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment. Transl Oncol Chen H, Yang W, Ma L, Li Y, Ji Z. PMID: 37722291 [PubMed - as supplied by publisher]
	Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open Hwang C, Henderson NC, Chu SC, Holland B, Cackowski FC, Pilling A, Jang A, Rothstein S, Labriola M, Park JJ, Ghose A, Bilen MA, Mustafa S, Kilari D, Pierro MJ, Thapa B, Tripathi A, Garje R, Ravindra A, Koshkin VS, Hernandez E, Schweizer MT, Armstrong AJ, McKay RR, Dorff TB, Alva AS, Barata PC. PMID: 37721753 [PubMed - indexed for MEDLINE]
	Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity. Explor Target Antitumor Ther Bersanelli M, Gnetti L, Pilato FP, Varotti E, Quaini F, Campanini N, Rapacchi E, Camisa R, Carbognani P, Silini EM, Rusca M, Leonardi F, Maestroni U, Rizzo M, Brunelli M, Buti S, Ampollini L. PMID: 37720351 [PubMed]
	A Qualitative Study of Men's Experiences Using Navigate: A Localized Prostate Cancer Treatment Decision Aid. MDM Policy Pract Todio E, Schofield P, Sharp J. PMID: 37719768 [PubMed]
	Quality of Care for Prostate Cancer in Kashmir, India: A Real-World Study. Cureus Akhtar OS, Andrabi SAR, Bhat PS, Akhtar SS. PMID: 37719520 [PubMed]

Articles 1 - 20 / 164625

Page 1 of 8232



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy